(Q35555391)
Statements
Preliminary results of safety and efficacy of the interleukin 1 receptor antagonist anakinra in patients with severe lupus arthritis (English)
Ostendorf B
Iking-Konert C
Kurz K
Jung G
2 September 2004
scientific article published on 2 September 2004